4,503
Views
61
CrossRef citations to date
0
Altmetric
Research Article

Synthesis and characterization of PEG-functionalized graphene oxide as an effective pH-sensitive drug carrier

, , &
Pages 90-94 | Received 15 Sep 2018, Accepted 16 Oct 2018, Published online: 19 Jan 2019

References

  • Aqel A, El-Nour KMA, Ammar RA, et al. Carbon nanotubes, science and technology part (I) structure, synthesis and characterisation. Arabian J Chem. 2012;5:1–23.
  • Gogotsi Y, Presser V. Carbon nanomaterials. Tylor Francis; 2013.
  • Wang Y, Li Z, Wang J, et al. Graphene and graphene oxide: biofunctionalization and applications in biotechnology. Trends Biotechnol. 2011;29:205–212.
  • Abbasi E, Akbarzadeh A, Kouhi M, et al. Graphene: synthesis, bio-applications, and properties. Artif Cells Nanomed Biotechnol. 2016;44:150–156.
  • Ma N, Liu J, He W, et al. Folic acid-grafted bovine serum albumin decorated graphene oxide: an efficient drug carrier for targeted cancer therapy. J Colloid Interface Sci. 2017;490:598–607.
  • Ma N, Zhang B, Liu J, et al. Green fabricated reduced graphene oxide: evaluation of its application as nano-carrier for pH-sensitive drug delivery. Int J Pharm. 2015;496:984–992.
  • Zhang L, Xia J, Zhao Q, et al. Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs. Small. 2010;6:537–544.
  • Liu J, Tang J, Gooding JJ. Strategies for chemical modification of graphene and applications of chemically modified graphene. J Mater Chem. 2012;22:12435–12452.
  • Dreyer DR, Park S, Bielawski CW, et al. The chemistry of graphene oxide. Chem Soc Rev. 2010;39:228–240.
  • Nejati-Koshki K, Mesgari M, Ebrahimi E, et al. Synthesis and in vitro study of cisplatin-loaded Fe3O4 nanoparticles modified with PLGA-PEG6000 copolymers in treatment of lung cancer. J Microencapsul. 2014;31:815–823.
  • More MP, Patil MD, Pandey AP, et al. Fabrication and characterization of graphene-based hybrid nanocomposite: assessment of antibacterial potential and biomedical application. Artif Cells Nanomed Biotechnol. 2016;45:1–13.
  • Gürel HH, Salmankurt B. Biological applications of graphene oxide. AIP Publishing; 2016.
  • Liu J, Cui L, Losic D. Graphene and graphene oxide as new nanocarriers for drug delivery applications. Acta Biomater. 2013;9:9243–9257.
  • Ajami M, Davoodi SH, Habibey R, et al. Effect of DHA + EPA on oxidative stress and apoptosis induced by ischemia-reperfusion in rat kidneys. Fundam Clin Pharmacol. 2013;27:593–602.
  • Deshpande A, Rhodes C, Shah N, et al. Controlled-release drug delivery systems for prolonged gastric residence: an overview. Drug Dev Ind Pharm. 1996;22:531–539.
  • Heil RW, Jr, Kenknight BH. Controlled release drug delivery. Google Patents. 2001
  • Georgakilas V, Otyepka M, Bourlinos AB, et al. Functionalization of graphene: covalent and non-covalent approaches, derivatives and applications. Chem Rev. 2012;112:6156–6214.
  • Pham TA, Kumar NA, Jeong YT. Covalent functionalization of graphene oxide with polyglycerol and their use as templates for anchoring magnetic nanoparticles. Synthetic Metals. 2010;160:2028–2036.
  • Georgakilas V, Tiwari JN, Kemp KC, et al. Noncovalent functionalization of graphene and graphene oxide for energy materials, biosensing, catalytic, and biomedical applications. Chem Rev. 2016;116:5464–5519.
  • Ebrahimi E, Akbarzadeh A, Abbasi E, et al. Novel drug delivery system based on doxorubicin-encapsulated magnetic nanoparticles modified with PLGA-PEG1000 copolymer. Artif Cells Nanomed Biotechnol. 2016;44:290–297.
  • Herranz MÁ, Martín N. Noncovalent functionalization of carbon nanotubes. In: Dirk MG, Martin N, editors. Carbon nanotubes and related structures: synthesis, characterization, functionalization, and applications. Wiley‐VCH Verlag GmbH & Co. KGaA; 2010. p. 103–134.
  • Pazoki-Toroudi H, Nassiri-Kashani M, Tabatabaie H, et al. Combination of azelaic acid 5% and erythromycin 2% in the treatment of acne vulgaris. Cutaneous Ocul Toxicol. 2010;30:286–291.
  • Langer R, Chasin M. Biodegradable polymers as drug delivery systems. Informa Health Care. 1990.
  • Allen TM, Cullis PR. Drug delivery systems: entering the mainstream. Science. 2004;303:1818–1822.
  • Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B. 2010;75:1–18.
  • Pasut G, Veronese FM. PEG conjugates in clinical development or use as anticancer agents: an overview. Adv Drug Deliv Rev. 2009;61:1177–1188.
  • Sezgin Z, Yüksel N, Baykara T. Preparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugs. Eur J Pharm Biopharm. 2006;64:261–268.
  • Pazoki-Toroudi H, Nassiri-Kashani M, Tabatabaie H, et al. Combination of azelaic acid 5% and erythromycin 2% in the treatment of acne vulgaris. J Dermatolog Treat. 2010;21:212–216.
  • Mei Q, Zhang K, Guan G, et al. Highly efficient photoluminescent graphene oxide with tunable surface properties. Chem Commun (Camb). 2010;46:7319–7321.
  • Mansourpanah Y, Shahebrahimi H, Kolvari E. PEG-modified GO nanosheets, a desired additive to increase the rejection and antifouling characteristics of polyamide thin layer membranes. Chem Eng Res Design. 2015;104:530–540.
  • Zhu H, Gao L, Jiang X, et al. Positively charged graphene oxide nanoparticle: precisely label the plasma membrane of live cell and sensitively monitor extracellular pH in situ. Chem Commun (Camb). 2014;50:3695–3698.
  • Badrzadeh F, Akbarzadeh A, Zarghami N, et al. Comparison between effects of free curcumin and curcumin loaded NIPAAm-MAA nanoparticles on telomerase and PinX1 gene expression in lung cancer cells. Asian Pac J Cancer Prev. 2014;15:8931–8936.
  • Wang C, Feng L, Yang H, et al. Graphene oxide stabilized polyethylene glycol for heat storage. Phys Chem Chem Phys. 2012;14:13233–13238.